Prostate cancer topography and patterns of lymph node metastasis
- PMID: 21107093
- PMCID: PMC3414911
- DOI: 10.1097/PAS.0b013e3181fc679e
Prostate cancer topography and patterns of lymph node metastasis
Abstract
Pelvic lymph node (LN) metastasis is a well-recognized route of prostate cancer spread. However, the relationship between topography and the pathologic features of primary prostatic cancers and patterns of pelvic LN metastasis has not been well studied. We reviewed original slides of radical prostatectomies and pelvic LN dissections from 125 patients with LN metastasis and recorded a total number of LN excised/laterality of positive LN, and localization, staging parameters, lymphovascular invasion, and volume of primary tumors.
Ln quantity and distribution: 14.6 (mean) and 13 (median) LNs were resected. Seventy-six (61%), 33 (26%), and 16 (13%) cases had 1, 2, and >2 positive LNs; whereas 58, 44, and 20 cases had LN metastasis on the right, left, and bilaterally.
Pathologic features: Eighty-six percent (108 of 125) and 37% (46 of 125) of the cases showed extraprostatic extension and seminal vesicle invasion, whereas 64% cases showed lymphovascular invasion. Mean and median total tumor volumes were 6.39 and 3.92 cm, with ≥50% and ≥90% Gleason patterns 4/5 in 105 (84%) and 73 (58%) cases, respectively.
Correlation with dominant tumor location: Dominant lesions on radical prostatectomy were as follows: 50 right lobe, 44 left lobe, and 31 bilateral lobe tumors. Fifteen of 50 (30%) right lobe and 18 of 44 (41%) left lobe dominant tumors had LN metastasis on the contralateral side. Only 4% (5 of 125) of the cases were associated with anterior dominant tumors.
Conclusion: Thirty percent to 40% of LN metastases occurred contralateral to the dominant tumor. LN metastasis is overwhelmingly associated with high-grade, high-stage, and large volume disease. LN positivity is rarely associated with anterior dominant tumors.
Figures


Similar articles
-
The role of side-specific biopsy and dominant tumor location at radical prostatectomy in predicting the side of nodal metastases in organ confined prostate cancer: is lymphatic spread really unpredictable?Minerva Urol Nefrol. 2019 Apr;71(2):146-153. doi: 10.23736/S0393-2249.18.03286-1. Epub 2018 Nov 7. Minerva Urol Nefrol. 2019. PMID: 30421597
-
Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens.Arch Pathol Lab Med. 2013 May;137(5):610-7. doi: 10.5858/arpa.2012-0128-OA. Arch Pathol Lab Med. 2013. PMID: 23627451
-
Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.Eur Urol. 2014 Aug;66(2):222-9. doi: 10.1016/j.eururo.2013.02.007. Epub 2013 Feb 18. Eur Urol. 2014. PMID: 23465520
-
[International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens].Ann Pathol. 2013 Jun;33(3):155-61. doi: 10.1016/j.annpat.2013.04.017. Epub 2013 May 29. Ann Pathol. 2013. PMID: 23790653 French.
-
[Intermediate and high risk prostate cancer patients. Clinical significance of extended lymphadenectomy].Urologe A. 2013 Feb;52(2):240-5. doi: 10.1007/s00120-012-3005-4. Urologe A. 2013. PMID: 23150089 Review. German.
Cited by
-
68Ga-labeled prostate specific membrane antigen HBED-CC PET/MRI for staging and evaluating the clinicopathological characteristics in newly diagnosed prostate cancer.Eur J Med Res. 2025 Apr 21;30(1):311. doi: 10.1186/s40001-025-02567-7. Eur J Med Res. 2025. PMID: 40259392 Free PMC article.
-
Pixel Prostate Software as a Reliable Tool in Depicting Spatial Distribution and Determination of the Prostate Cancer Volume.Acta Inform Med. 2019 Jun;27(2):89-95. doi: 10.5455/aim.2019.27.89-95. Acta Inform Med. 2019. PMID: 31452565 Free PMC article.
-
Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.Cell Death Dis. 2020 Jul 27;11(7):591. doi: 10.1038/s41419-020-02786-2. Cell Death Dis. 2020. PMID: 32719332 Free PMC article.
-
Sentinel node evaluation in prostate cancer.Clin Exp Metastasis. 2018 Aug;35(5-6):471-485. doi: 10.1007/s10585-018-9936-4. Epub 2018 Sep 5. Clin Exp Metastasis. 2018. PMID: 30187286 Review.
-
Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?J Clin Med. 2022 Apr 22;11(9):2343. doi: 10.3390/jcm11092343. J Clin Med. 2022. PMID: 35566471 Free PMC article. Review.
References
-
- Al-Ahmadie HA, Tickoo SK, Olgac S, et al. Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy. Am J Surg Pathol. 2008;32:229–235. - PubMed
-
- Allaf ME, Palapattu GS, Trock BJ, et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol. 2004;172:1840–1844. - PubMed
-
- Bader P, Burkhard FC, Markwalder R, et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol. 2002;168:514–518. - PubMed
-
- Bader P, Burkhard FC, Markwalder R, et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy: is there a chance of cure? J Urol. 2003;169:849–854. - PubMed
-
- Bott SRJ, Young MPA, Kellett MJ, et al. Anterior prostate cancer: is it more difficult to diagnose? BJU Int. 2002;89:886–889. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical